Juvenile Fibromyalgia: Different from the Adult Chronic Pain Syndrome?

Current Rheumatology Reports

Volumn 18, Issue 4, 2016, Pages

  Kashikar Zuck, Susmita ^a   King, Christopher ^a   Ting, Tracy V ^a   Arnold, Lesley M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adolescents; Chronic widespread pain (CWP); Fibromyalgia (FM); Juvenile fibromyalgia (JFM); Juvenile primary fibromyalgia syndrome (JPFS)

Indexed keywords

DULOXETINE; MILNACIPRAN; PLACEBO; PREGABALIN;

CHRONIC PAIN SYNDROME; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; DISEASE COURSE; DISEASE SEVERITY; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; FIBROMYALGIA; HUMAN; JOINT LAXITY; JUVENILE FIBROMYALGIA; PAIN; PHYSICAL ACTIVITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; AGE; CHRONIC PAIN; PSYCHOLOGY;

AGE FACTORS; CHRONIC PAIN; FIBROMYALGIA; HUMANS; PROGNOSIS;

EID: 84961640987     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-016-0569-9     Document Type: Review

References (62)

1. Mansfield KE, Sim J, Jordan JL, Jordan KP. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain. 2016;157(1):55–64. This paper presents the most recent population based statistics on the prevalence of chronic widespread pain.
2. Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PLoS One. 2015;10(9), e0138024.
3. Wolfe F, Brähler E, Hinz A, Häuser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res. 2013;65(5):777–85.
4. Buskila D, Press J, Gedalia A, Klein M, Neumann L, Boehm R, et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol. 1993;20(2):368–70.
5. Clark P, Burgos-Vargas R, Medina-Palma C, Lavielle P, Marina FF. Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol. 1998;25(10):2009–14.
6. Gerloni V, Ghirardini M, Fantini F. Assessment of nonarticular tenderness and prevalence of primary fibromyalgia syndrome in healthy Italian schoolchildren. Arthritis Rheum. 1998;41(9):1405.
7. Yunus MB, Masi AT. Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls. Arthritis Rheum. 1985;28(2):138–45. The first study that provided recognition of juvenile fibromyalgia as a syndrome in youth and suggested criteria for its proper classification.
8. Gedalia A, Garcia CO, Molina JF, Bradford NJ, Espinoza LR. Fibromyalgia syndrome: experience in a pediatric rheumatology clinic. Clin Exp Rheumatol. 2000;18(3):415–9.
9. Kashikar-Zuck S, Parkins IS, Ting TV, Verkamp E, Lynch-Jordan A, Passo M, et al. Controlled follow-up study of physical and psychosocial functioning of adolescents with juvenile primary fibromyalgia syndrome. Rheumatology (Oxford). 2010;49(11):2204–9.
10. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600–10. The most recent criteria for diagnosis of adult FM which introduced the concept of assessment of widespread pain and somatic symptom severity using standardized rating scale. Also suggested that the tender point exam was not necessary to meet criteria for FM.
11. Ting TV, Barnett K, Lynch-Jordan A, Whitacre C, Henrickson M, Kashikar-Zuck S. 2010 American College of Rheumatology adult fibromyalgia criteria for use in an adolescent female population with juvenile fibromyalgia. J Pediatr. 2016;169:181–87. This study demonstrated that the ACR 2010 criteria for adult FM could be applied in a sample of adolescent females with JFM with high sensitivity and specificity.
12. Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken). 2014;66(9):1364–73.
13. Kashikar-Zuck S, Ting TV, Arnold LM, Bean J, Powers SW, Graham TB, et al. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum. 2012;64(1):297–305. This is the only published randomized clinical trial of cognitive-behavioral therapy (CBT) for JFM. Results showed strong improvements in functional disability after an 8-week CBT intervention.
14. Kashikar-Zuck S, Vaught MH, Goldschneider KR, Graham TB, Miller JC. Depression, coping and functional disability in juvenile primary fibromyalgia syndrome. J Pain. 2002;3(5):412–9.
15. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50(3):944–52.
16. Kashikar-Zuck S, Lynch AM, Slater S, Graham TB, Swain NF, Noll RB. Family factors, emotional functioning, and functional impairment in juvenile fibromyalgia syndrome. Arthritis Rheum. 2008;59(10):1392–8.
17. Kashikar-Zuck S, Parkins IS, Graham TB, Lynch AM, Passo M, Johnston M, et al. Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome. Clin J Pain. 2008;24(7):620–6.
18. Reid GJ, Lang BA, McGrath PJ. Primary juvenile fibromyalgia: psychological adjustment, family functioning, coping, and functional disability. Arthritis Rheum. 1997;40(4):752–60.
19. Kashikar-Zuck S, Johnston M, Ting TV, Graham BT, Lynch-Jordan AM, Verkamp E, et al. Relationship between school absenteeism and depressive symptoms among adolescents with juvenile fibromyalgia. J Pediatr Psychol. 2010;35(9):996–1004.
20. Kashikar-Zuck S, Lynch AM, Graham TB, Swain NF, Mullen SM, Noll RB. Social functioning and peer relationships of adolescents with juvenile fibromyalgia syndrome. Arthritis Rheum. 2007;57(3):474–80.
21. Kashikar-Zuck S, Zafar M, Barnett KA, Aylward BS, Strotman D, Slater SK, et al. Quality of life and emotional functioning in youth with chronic migraine and juvenile fibromyalgia. Clin J Pain. 2013;29(12):1066–72.
22. Varni JW, Burwinkle TM, Limbers CA, Szer IS. The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains. Health Qual Life Outcomes. 2007;5:9.
23. Varni JW, Limbers CA, Burwinkle TM. Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core Scales. Health Qual Life Outcomes. 2007;5(1):43.
24. Kashikar-Zuck S, Flowers SR, Verkamp E, Ting TV, Lynch-Jordan AM, Graham TB, et al. Actigraphy-based physical activity monitoring in adolescents with juvenile primary fibromyalgia syndrome. J Pain. 2010;11(9):885–93.
25. Gedalia A, Press J, Klein M, Buskila D. Joint hypermobility and fibromyalgia in schoolchildren. Ann Rheum Dis. 1993;52(7):494–6.
26. Ting TV, Hashkes PJ, Schikler K, Desai AM, Spalding S, Kashikar-Zuck S. The role of benign joint hypermobility in the pain experience in juvenile fibromyalgia: an observational study. Pediatric Rheumatol. 2012;10(1):16. This study documented that joint hypermobility is present in ∼40% of adolescent patients with JFM.
27. Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr. 1999;135(4):494–9.
28. Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006;67(8):1219–25.
29. Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics. 1999;40(1):57–63.
30. Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain. 2006;124(1–2):117–25.
31. Cunningham NR, Tran ST, Lynch-Jordan AM, Ting TV, Sil S, Strotman D, et al. Psychiatric disorders in young adults diagnosed with juvenile fibromyalgia in adolescence. J Rheumatol. 2015;42(12):2427–33.
32. Buskila D, Neumann L, Hershman E, Gedalia A, Press J, Sukenik S. Fibromyalgia syndrome in children: an outcome study. J Rheumatol. 1995;22(3):525–8.
33. Mikkelsson M. One year outcome of preadolescents with fibromyalgia. J Rheumatol. 1999;26(3):674–82.
34. Mikkelsson M, Salminen JJ, Kautiainen H. Non-specific musculoskeletal pain in preadolescents. Prevalence and 1-year persistence. Pain. 1997;73(1):29–35.
35. Siegel DM, Janeway D, Baum J. Fibromyalgia syndrome in children and adolescents: clinical features at presentation and status at follow-up. Pediatrics. 1998;101(3 Pt 1):377–82.
36. Kashikar-Zuck S, Cunningham N, Sil S, Bromberg MH, Lynch-Jordan AM, Strotman D, et al. Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood. Pediatrics. 2014;133(3):e592–600. This controlled study of the outcomes of JFM patients over a 6-year follow-up period showed that the majority continued to be symptomatic and 51% met full ACR criteria for adult FM.
37. Arnold LM, Bateman L, Palmer RH, Lin Y. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. Pediatr Rheumatol. 2015;13(1):1–14.
38. Mariutto EN, Stanford SB, Kashikar-Zuck S, Welge JA, Arnold LM. An exploratory, open trial of fluoxetine treatment of juvenile fibromyalgia. J Clin Psychopharmacol. 2012;32(2):293–5.
39. Arnold L, Bateman L, Schikler KN, Khan T, Pauer L, Bhadra Brown P, Chew ML, Clair A, Scavone J. A randomized, controlled trial of pregabalin in adolescent patients (12–17 years) with fibromyalgia [abstract]. Arthritis Rheum. 2015;Suppl 10:67.
40. Arnold LM, Sarzi-Puttini P, Arsenault P, Khan T, Bhadra Brown P, Clair A, et al. Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, placebo-controlled study. J Rheumatol. 2015;42(7):1237–44.
41. Kashikar-Zuck S, Swain NF, Jones BA, Graham TB. Efficacy of cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome. J Rheumatol. 2005;32(8):1594–602.
42. Bernardy K, Fuber N, Kollner V, Hauser W. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome—a systematic review and metaanalysis of randomized controlled trials. J Rheumatol. 2010;37(10):1991–2005.
43. Glombiewski JA, Sawyer AT, Gutermann J, Koenig K, Rief W, Hofmann SG. Psychological treatments for fibromyalgia: a meta-analysis. Pain. 2010;151(2):280–95.
44. Busch AJ, Barber KA, Overend TJ, Peloso PM, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007;4, CD003786.
45. Gowans SE, de Hueck A. Effectiveness of exercise in management of fibromyalgia. Curr Opin Rheumatol. 2004;16(2):138–42.
46. Stephens S, Feldman BM, Bradley N, Schneiderman J, Wright V, Singh-Grewal D, et al. Feasibility and effectiveness of an aerobic exercise program in children with fibromyalgia: results of a randomized controlled pilot trial. Arthritis Rheum. 2008;59(10):1399–406.
47. Kashikar-Zuck S, Flowers SR, Strotman D, Sil S, Ting TV, Schikler KN. Physical activity monitoring in adolescents with juvenile fibromyalgia: findings from a clinical trial of cognitive-behavioral therapy. Arthritis Care Res (Hoboken). 2013;65(3):398–405.
48. Sherry DD, Brake L, Tress JL, Sherker J, Fash K, Ferry K, et al. The treatment of juvenile fibromyalgia with an intensive physical and psychosocial program. J Pediatr. 2015;167(3):731–7.
49. Sil S, Thomas S, DiCesare C, Strotman D, Ting T, Myer G, Kashikar-Zuck S. (159) Fear of movement and physical deconditioning in adolescents with juvenile fibromyalgia [Abstract]. J Pain. 2014;15(4 Suppl):15.
50. Sil S, Thomas S, DiCesare C, Strotman D, Ting TV, Myer G, et al. Preliminary evidence of altered biomechanics in adolescents with juvenile fibromyalgia. Arthritis Care Res (Hoboken). 2015;67(1):102–11.
51. Rabbitts JA, Holley AL, Karlson CW, Palermo TM. Bidirectional associations between pain and physical activity in adolescents. Clin J Pain. 2014;30(3):251–8.
52. Nijs J, Kosek E, Van Oosterwijck J, Meeus M. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise? Pain Physician. 2012;15(3S):ES205–13.
53. Staud R, Robinson ME, Price DD. Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain. 2005;118(1):176–84.
54. Thomas SM, Sil S, Kashikar-Zuck S, Myer GD. Can modified neuromuscular training support the treatment of chronic pain in adolescents? Strength Cond J. 2013;35(3):12–26.
55. Kashikar-Zuck S, Tran ST, Barnett K, Bromberg MH, Strotman D, Sil S, et al. A qualitative examination of a new combined cognitive-behavioral and neuromuscular training intervention for juvenile fibromyalgia. Clin J Pain. 2016;32(1):70–81. This study describes a new integrative training intervention for the management of JFM which combines CBT with physical exercises based on an injury-prevention approach derived from Sports Medicine to improve movement competence via gait, strength and balance training.
56. Castro‐Sánchez AM, Matarán‐Peñarrocha GA, López‐Rodríguez MM, Lara‐Palomo IC, Arendt‐Nielsen L, Fernández‐de‐las‐Peñas C. Gender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions. Pain Med. 2012;13(12):1639–47.
57. Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, et al. Subgrouping of fibromyalgia patients on the basis of pressure‐pain thresholds and psychological factors. Arthritis Rheum. 2003;48(10):2916–22.
58. Staud R, Vierck CJ, Robinson ME, Price DD. Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J Pain. 2005;6(5):323–32.
59. Staud R. Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia. Rheum Dis Clin N Am. 2009;35(2):263–74.
60. Staud R. Brain imaging in fibromyalgia syndrome. Clin Exp Rheumatol. 2010;29(6 Suppl 69):S109–17.
61. Ablin JN, Buskila D, Clauw DJ. Biomarkers in fibromyalgia. Curr Pain Headache Rep. 2009;13(5):343–9.
62. Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011;13(6):513–20.